CXCL12 and cancer: The chemokine CXCL12 and its cognate receptor CXCR4, a transcriptional target of FOXC1 was shown to play central roles in cancer proliferation, angiogenesis, invasion, tumor microenvironment, as well as drug resistance induced by chemotherapy (85).